ArticleTobacco induced diseases2026
PRKN Ser131 phosphorylation promotes cigarette smoke-induced mitophagy impairment and epithelial cell senescence via MKK3/p38 MAPK activation: An in vitro and in vivo study.
Article in Tobacco induced diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCigarette smoke (CS) exposure impairs mitochondrial function and promotes senescence in airway epithelial cells, contributing to the pathogenesis of chronic obstructive pulmonary disease (COPD). However, the molecular mechanisms linking mitophagy dysfunction to cellular senescence remain poorly understood. Parkin (PRKN) is a key regulator of mitophagy, but whether PRKN Ser131 phosphorylation contributes to CS-induced impairment of mitophagy and senescence remains unclear. Therefore, this study aimed to investigate the role of PRKN Ser131 phosphorylation in CS-induced impairment of mitophagy and epithelial cell senescence, and to explore the underlying mechanism.
methodsThis laboratory-based experimental study utilized human bronchial epithelial BEAS-2B cells exposed to cigarette smoke extract (CSE) and a mouse model of CS-induced emphysema. Molecular interventions included mutation of PRKN at Ser131, and knockdown of mitogen-activated protein kinase kinase 3 (MKK3) to modulate the downstream p38 mitogen-activated protein kinase (p38 MAPK) pathway. Mitophagy activity, mitochondrial reactive oxygen species (ROS), and senescence markers were evaluated.
resultsExposure to cigarette smoke extract (CSE) increased MKK3 expression and activated the p38 MAPK pathway, leading to phosphorylation of PRKN at Ser131. This phosphorylation was accompanied by reduced mitophagy-related readouts and increased mitochondrial ROS. Both MKK3 knockdown and modulation of mitochondrial quality-control pathways were associated with improved mitophagy-related readouts and reduced senescence markers under CSE exposure. Moreover, cells expressing the PRKN S131A mutant exhibited significantly improved mitophagy flux, reduced ROS levels, and attenuated senescence compared to wild-type PRKN.
conclusionsOur findings suggest that the MKK3/p38 MAPK-PRKN Ser131 axis contributes to CS-induced mitophagy impairment and epithelial senescence. Additional studies are needed to strengthen the evidence and evaluate the translational potential of targeting this pathway in COPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.